{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T20:10:11Z","timestamp":1756671011517,"version":"3.44.0"},"reference-count":19,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"unspecified","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Chongqing Study abroad Innovation Program","award":["cx2018141"],"award-info":[{"award-number":["cx2018141"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2023,7,28]]},"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Pneumonia is the main complication of the Omicron variant of SARS-CoV-2; however, the incidence proportions and prognostic factors for Omicron-associated pneumonia have not been established. We conducted this study to characterise the incidence proportions and influence of various factors on prognosis of Omicron-associated pneumonia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We collected data from 714 patients infected with the Omicron variant in The First Affiliated Hospital of Chongqing Medical University (Chongqing, China) who were divided into different groups for analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 313 patients with Omicron-associated pneumonia at the time of diagnosis of patients infected with the Omicron variant, representing 43.8% of the entire cohort. A total of 82 were 15\u201359 years old, 71 were 60\u201369 years old, 76 were 70\u201379 years old and 84 were &gt;80 years old. 133 were female and 180 were male. Incidence proportions of pneumonia were highest among patients with cardiovascular (82.4% of the basic disease of the cardiovascular system subset) or kidney disease (92.3% of the kidney disease subset), whereas patients with lung cancer (35.7% of the lung cancer subset) had a lower incidence proportion. Several factors were associated with the prognosis of pneumonia in patients infected with the Omicron variant. Patients with a thrombosis or pleural effusion had a longer hospitalisation time. Paxlovid and immunoglobulins improved the prognosis of patients with severe pneumonia. The following measures were significantly different in patients as a function of disease severity: number of neutrophils and lymphocytes, partial oxygen pressure; and myoglobin, lactic dehydrogenase, aspartate transaminase and procalcitonin levels.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Patients infected with the Omicron variant with coexisting cardiovascular or kidney disease, but not respiratory disease, had a higher incidence proportion of pneumonia. Paxlovid and immunoglobulins can be used in patients with severe infections to improve prognosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2023-001729","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T13:31:20Z","timestamp":1691069480000},"page":"e001729","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Pneumonia in newly diagnosed patients infected with the Omicron variant: a population-based study of Chinese patients in Chongqing"],"prefix":"10.1136","volume":"10","author":[{"given":"Huyu","family":"Wang","sequence":"first","affiliation":[{"name":"Chongqing Medical University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rouqian","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[{"name":"Chongqing Medical University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Shui","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4283-9520","authenticated-orcid":false,"given":"Yajuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,8,3]]},"reference":[{"doi-asserted-by":"publisher","key":"2025083112413582000_10.1.e001729.1","DOI":"10.12998\/wjcc.v10.i1.1"},{"unstructured":"Aleem A , Akbar Samad AB , Slenker AK . Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19). Treasure Island (FL): StatPearls Publishing, 2022.","key":"2025083112413582000_10.1.e001729.2"},{"key":"2025083112413582000_10.1.e001729.3","article-title":"Subclinical myocardial injury, Coagulopathy, and inflammation in COVID-19: A meta-analysis of 41,013 hospitalized patients","volume":"40","author":"Ogungbe","year":"2022","journal-title":"Int J Cardiol Heart Vasc"},{"key":"2025083112413582000_10.1.e001729.4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ajem.2022.01.028","article-title":"Clinical update on COVID-19 for the emergency clinician: presentation and evaluation","volume":"54","author":"Long","year":"2022","journal-title":"The American Journal of Emergency Medicine"},{"unstructured":"COVID-19 Treatment Guidelines Panel . Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. n.d. Available: https:\/\/www.covid19treatmentguidelines.nih.gov\/","key":"2025083112413582000_10.1.e001729.5"},{"key":"2025083112413582000_10.1.e001729.6","first-page":"449","article-title":"Analysis of clinical characteristics and prognosis of 4 264 patients with asymptomatic and mild novel Coronavirus infections in Shanghai","volume":"34","author":"Xu","year":"2022","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"2025083112413582000_10.1.e001729.7","first-page":"1199","article-title":"Clinical characteristics of patients infected with 2019-nCoV Omicron variants BA.2 and BA.5 in Xi'An city, China","volume":"45","author":"Shang","year":"2022","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"2025083112413582000_10.1.e001729.8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.diagmicrobio.2011.01.005","article-title":"Pneumonia risk factors and clinical features of hospitalized patients older than 15 years with pandemic influenza A (H1N1) in South Korea: a multicenter study","volume":"70","author":"Jeon","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2025083112413582000_10.1.e001729.9","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4046\/trd.2016.0015","article-title":"Incidence and risk factors of pneumonia in hospitalized patients with seasonal influenza A or B","volume":"80","author":"Chu","year":"2017","journal-title":"Tuberc Respir Dis"},{"key":"2025083112413582000_10.1.e001729.10","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-015-1004-y","article-title":"Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection-United States, 2005-2008","volume":"15","author":"Garg","year":"2015","journal-title":"BMC Infect Dis"},{"doi-asserted-by":"publisher","key":"2025083112413582000_10.1.e001729.11","DOI":"10.1016\/j.jacc.2020.04.031"},{"doi-asserted-by":"publisher","key":"2025083112413582000_10.1.e001729.12","DOI":"10.1016\/j.thromres.2020.04.013"},{"key":"2025083112413582000_10.1.e001729.13","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-020-03260-3","article-title":"Thrombotic and Haemorrhagic complications in critically ill patients with COVID-19: A Multicentre observational study","volume":"24","author":"Shah","year":"2020","journal-title":"Crit Care"},{"doi-asserted-by":"publisher","key":"2025083112413582000_10.1.e001729.14","DOI":"10.1136\/jim-2021-002161"},{"key":"2025083112413582000_10.1.e001729.15","first-page":"223","article-title":"Clinical and laboratory characteristics of the COVID-19 disease in adult patients","volume":"41","author":"\u0160\u00edn","year":"2020","journal-title":"Neuro Endocrinol Lett"},{"doi-asserted-by":"publisher","key":"2025083112413582000_10.1.e001729.16","DOI":"10.1016\/j.ajic.2020.06.008"},{"key":"2025083112413582000_10.1.e001729.17","doi-asserted-by":"crossref","first-page":"7429","DOI":"10.21037\/jtd-20-1743","article-title":"Risk factors and predictors associated with the severity of COVID-19 in China: a systematic review, meta-analysis, and meta-regression","volume":"12","author":"Zhang","year":"2020","journal-title":"J Thorac Dis"},{"key":"2025083112413582000_10.1.e001729.18","doi-asserted-by":"crossref","DOI":"10.1186\/s40001-020-00432-3","article-title":"Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis","volume":"25","author":"Ghahramani","year":"2020","journal-title":"Eur J Med Res"},{"key":"2025083112413582000_10.1.e001729.19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.dsx.2021.02.020","article-title":"A systematic review of clinical and laboratory parameters associated with increased severity among COVID-19 patients","volume":"15","author":"Mehta","year":"2021","journal-title":"Diabetes Metab Syndr"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2023-001729","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T19:41:43Z","timestamp":1756669303000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2023-001729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,8,3]]},"published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1136\/bmjresp-2023-001729"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2023-001729","relation":{},"ISSN":["2052-4439"],"issn-type":[{"type":"electronic","value":"2052-4439"}],"subject":[],"published":{"date-parts":[[2023,8]]}}}